🔗 Share this article

A shadow market for unapproved slimming medications is being driven by TikTok fitness influencers and sellers on communication apps, based on new investigations.

Experimental Drug Gaining Popularity Online

The experimental drug, which remains in clinical trials, is being promoted by social media influencers for its supposed weight-reducing effects. Followers are encouraged to contact these accounts privately for supplier links, while also receiving discount codes.

Thriving Commerce on Messaging Platforms

Additionally, a flourishing trade exists on Telegram, where communities with thousands of members share comparison photos, administration instructions and assertions of next-day British shipping. Sellers promote the drug there before redirecting customers to other platforms for purchases.

Learning About Retatrutide

This medication is an experimental injection created by American pharmaceutical company Eli Lilly. The drug targets three gut hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and glucagon. Preliminary studies suggest it could assist individuals lose up to a quarter of their body weight. Nicknamed the “triple G”, the drug is being hailed digitally as the successor to Ozempic.

Medical Experts Express Worries

However, doctors and pharmacists have cautions that the sale of what is still an unlicensed medication in the United Kingdom is a cause for concern and could lead to users injecting products of unknown origin.

Several experts stated the demand for retatrutide could be linked to the increasing price of approved weight loss treatments such as Mounjaro.

Legal Position and Implementation

Marketing retatrutide on TikTok or messaging apps is prohibited in the UK, as it is an unlicensed medication that cannot be marketed or distributed for personal consumption under the British medical regulations.

Several influencers attempt to sidestep the regulations by calling to the substance as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a controlled drug, but promotion and supply can still violate medicines, advertising, and customer regulations, potentially leading to penalties, prosecution or prison.

Service Response and Material Removal

Based on the social media company, the service has taken down problematic material and prohibited associated keywords and search suggestions. The organization said it was committed to keeping the service secure and investing in enhancing enforcement strategies.

Digital Marketplace Operations

Research also discovered communities with up to 9,000 members selling retatrutide using the platform's built-in search feature, which functions like a online catalog. Typing “retatrutide” immediately brings up groups with thousands of users, filled with photos of slimming results, positive reviews and detailed guides for preparing or administering at residence.

Within minutes of joining one group, a seller posted WhatsApp details, where most purchases take place. The vendor provided an guidebook and promised shipping within 48 hours. When asked whether the product was authentic, one seller said: “You can’t be sure.” Another shared a photo of a supposed laboratory certificate. None inquired about body mass, health issues or previous experience.

Item Information and Costs

Within these groups, messages display black plastic packages with Royal Mail labels, stating to include new batches. One communication stated: “It took eight of us to load them this morning.”

Buyers can choose between dry substance containers, prepared at home with sterile water, or pre-filled injectors usually priced at 160 pounds for 20 milligrams. When questioned how much time a pen should last, sellers give contradictory responses varying between a few weeks to “depends on your body”.

Platform Moderation and Safety Measures

A representative for the messaging service said it regularly moderated dangerous content on its platform including material that promoted the “misuse of controlled medications”. The company added that it removed “millions of pieces of harmful content each day”.

Healthcare Professional Cautions

“People are administering substances they cannot confirm. Even if the research behind this drug is sound, these digital versions may not include what they advertise,” stated a pharmacy expert, the director of pharmaceutical services at Chemist4U.

A medical professional of an online medical service linked the surge in interest to current price rises for approved weight-loss drugs such as Mounjaro. “With prices rising, individuals are using social media. But counterfeit injections are extremely risky. You cannot know what’s inside or whether the environment they were produced in was sterile,” she said.

Her staff has already encountered patients injured by personal administration from unconfirmed suppliers. “We recognize the frustration, but buying from Telegram or WhatsApp is taking chances with your health,” stated Wyllie. “These materials could be contaminated or incorrectly dosed.”

Manufacturer Position

A representative from Eli Lilly said retatrutide was in phase 3 clinical trials and had not been evaluated or authorized by any government authority anywhere in the world. “Consequently at this point no one can market [it] for human use,” they said, adding that any product “falsely representing itself as a Lilly investigational substance not yet authorized … may subject patients to possibly serious medical dangers”.